Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iskandar Idris

Showing results (121-130 of 122) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 122 results.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humansHenning Tim Langer, Natalie K Gilmore, Chris M T Hayden, et al.
Cell Reports. Medicine|March 18, 2026
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humansHenning Tim Langer, Natalie K Gilmore, Christopher M T Hayden, et al.
Pageof 13

Showing results (121-130 of 122) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 122 results.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humansHenning Tim Langer, Natalie K Gilmore, Chris M T Hayden, et al.
Cell Reports. Medicine|March 18, 2026
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humansHenning Tim Langer, Natalie K Gilmore, Christopher M T Hayden, et al.
Pageof 13